Building access to the Regenstrief Institute is restricted through early 2021. More on our coronavirus precautions.
See our coronavirus precautions.

Dr. Noll Campbell, Dr. Babar Khan, and Dr. Sikandar Khan man “mission control” during the meeting.

The COVID-19 pandemic has posed many challenges for conference organizers around the world. Two Regenstrief Institute research scientists successfully adjusted the American Delirium Society (ADS) conference from in-person to virtual and attracted more than 400 registrations from around the world.

The digital meeting was co-chaired by Indiana University Center for Aging Research at Regenstrief Institute Associate Director Babar Khan, M.D., M.S., and Regenstrief research scientist Noll Campbell, PharmD, M.S. Dr. Khan was the 2019-2020 president of the ADS, and Dr. Campbell is the ADS treasurer.

Regenstrief research scientist Sikandar Khan, D.O., and Indiana University School of Medicine administrative coordinator Makenna Flory assisted with managing the technology during the presentations.

The digital meeting featured about three dozen experts discussing the latest delirium-related research. The ADS works to lead the effort to foster research, education, quality improvement, advocacy and implementation science to minimize the impact of delirium on the health and wellbeing of patients.

Regenstrief researchers are pioneers in the field of delirium and have played an important role in the diagnosis and treatment of ADS. Regenstrief scientist Malaz Boustani, M.D., MPH, was the founding president of the organization.

The next meeting will take place in Indianapolis in March 2021.

Related Influence

Oct 21, 2020 • Influence
COVID-19 and the ICU: Regenstrief expert shares experience providing care for patients
Indiana University Center for Aging Research at Regenstrief Institute Associate Director Babar Khan, M.D., M.S., has been treating patients in the intensive care unit (ICU) throughout the COVID-19 pandemic.   Dr. Khan said many patients continue to suffer from mental, physical and emotional impairments after being released from the ICU, and those problems can persist for months. He…
Continue Reading >
Oct 07, 2020 • Influence
Evaluating the link between medications and dementia: Regenstrief researcher provides consultation
Regenstrief Institute research scientist Noll Campbell, PharmD, M.S., recently contributed to a study that made national headlines and provided more evidence that anticholinergic medications are linked to cognitive decline. The results from the study, led by researchers at the University of California San Diego School of Medicine, were published in Neurology. The authors concluded that…
Continue Reading >